Bo Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bo Liu has a total of 188 co-authors. Here are the top co-authors by number of shared publications:
- Yuan-Di Zhao
Britton Chance Center for Biomedical Photonics at Wuhan National Laboratory for Optoelectronics-Hubei Bioinformatics & Molecular Imaging Key Laboratory, Department of Biomedical Engineering, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, P. R. China
39 shared publications Jie Yang
Innovation Institute for Biomedical Materials College of Nursing and Health Management & College of Life Science and Chemistry Wuhan Donghu University Wuhan Hubei P. R. China
21 shared publicationsBin Zhang
MOE Key Laboratory for Biomedical Photonics - Hubei Bioinformatics & Molecular Imaging Key Laboratory, Department of Biomedical Engineering, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, PR China
15 shared publicationsDong-Hui Zhao
Britton Chance Center for Biomedical Photonics at Wuhan National Laboratory for Optoelectronics-Hubei Bioinformatics and Molecular Imaging Key Laboratory, Department of Biomedical Engineering, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan 430074, Hubei, PR China
13 shared publicationsMing-Hao Yao
Britton Chance Center for Biomedical Photonics at Wuhan National Laboratory for Optoelectronics – Hubei Bioinformatics & Molecular Imaging Key Laboratory
11 shared publicationsWei Chen
Britton Chance Center for Biomedical Photonics at Wuhan National Laboratory for Optoelectronics - Hubei Bioinformatics & Molecular Imaging Key Laboratory, Department of Biomedical Engineering, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, P. R. China
11 shared publications
Latest Publications
- Open Access
- 21 August 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
CD11b agonist GB1275 potentiates oncolytic bacterial therapy against pancreatic cancer in mouse tumor models
Oncolytic bacteria are microorganisms with cytotoxic activity capable of lysing cancer cells while simultaneously activating both innate and adaptive immune responses to exert anti-tumor effects. However, the innate immune activation targeting oncolytic bacteria within the tumor microenvironment (TME) is a limiting factor. Here we find that the CD11b-targeting agonist GB1275 can modulate bacteria-immune interaction and inhibit the infiltration of CD11b⁺ innate immune cells such as neutrophils and macrophages, thereby suppressing the antimicrobial immune defenses in the TME in mice. This then avoids the clearance of oncolytic bacteria and increases the efficacy of bacteria-mediated tumor immunotherapy. Furthermore, the gemcitabine-loaded bacteria combined with GB1275 treatment activate innate immune responses in tumor, as mediated by Toll-like receptors (TLR), NOD-like receptors (NLR) and cGAS-STING pathways, while simultaneously enhancing dendritic cell (DC)-dependent antigen cross-presentation; this then upregulates the adaptive anti-tumor immune response and inhibits the growth of both subcutaneous and in situ pancreatic cancers in mouse tumor models. Our results therefore demonstrate that modulating innate immune responses while subsequently strengthening adaptive immune activation can significantly improve the efficacy of bacteria-mediated tumor immunotherapy.
- 21 August 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessCD11b agonist GB1275 potentiates oncolytic bacterial therapy against pancreatic cancer in mouse tumor models
Oncolytic bacteria are microorganisms with cytotoxic activity capable of lysing cancer cells while simultaneously activating both innate and adaptive immune responses to exert anti-tumor effects. However, the innate immune activation targeting oncolytic bacteria within the tumor microenvironment (TME) is a limiting factor. Here we find that the CD11b-targeting agonist GB1275 can modulate bacteria-immune interaction and inhibit the infiltration of CD11b⁺ innate immune cells such as neutrophils and macrophages, thereby suppressing the antimicrobial immune defenses in the TME in mice. This then avoids the clearance of oncolytic bacteria and increases the efficacy of bacteria-mediated tumor immunotherapy. Furthermore, the gemcitabine-loaded bacteria combined with GB1275 treatment activate innate immune responses in tumor, as mediated by Toll-like receptors (TLR), NOD-like receptors (NLR) and cGAS-STING pathways, while simultaneously enhancing dendritic cell (DC)-dependent antigen cross-presentation; this then upregulates the adaptive anti-tumor immune response and inhibits the growth of both subcutaneous and in situ pancreatic cancers in mouse tumor models. Our results therefore demonstrate that modulating innate immune responses while subsequently strengthening adaptive immune activation can significantly improve the efficacy of bacteria-mediated tumor immunotherapy.
- 3 July 2026
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (30) , e71410
Multimetal‐Doped Nanoenzymes Reprogram Macrophages for Immunotherapy of Gouty Arthritis
The deposition of monosodium urate crystals triggers joint inflammation, which serves as a critical factor in gouty arthritis development. However, current monotherapy is unable to simultaneously reduce uric acid and suppress inflammation. We identified through bioinformatics and clinical sample analysis that oxidative stress‐related indicators were significantly elevated in patients with gouty arthritis. In light of this clinical finding, we developed a polydopamine‐based nanozyme with high superoxide dismutase and catalase activities via bimetallic ion coordination, which was subsequently loaded with uricase, rapamycin, and hyaluronic acid. In the gouty arthritis model, hyaluronic acid could target the CD44 receptor on the surface of macrophages, enhancing nanoprobe accumulation at the joint. The nanoprobe exhibited excellent biocompatibility and eliminated significantly monosodium urate crystals through multienzyme cascade reactions, while simultaneously addressing the accumulation of byproducts such as hydrogen peroxide, thereby markedly alleviating joint swelling and pain. In addition, the levels of Interleukin‐1 beta and Interleukin‐6 were significantly reduced, and the NF‐κB signaling pathway was effectively suppressed. The phenotypic of macrophages was transformed from pro‐inflammatory M1 to anti‐inflammatory M2 phenotype. Meanwhile, rapamycin effectively suppressed the immunogenicity of uricase and enhanced its therapeutic efficacy in vivo.
- 3 July 2026
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (30) , e71410
Multimetal‐Doped Nanoenzymes Reprogram Macrophages for Immunotherapy of Gouty Arthritis
The deposition of monosodium urate crystals triggers joint inflammation, which serves as a critical factor in gouty arthritis development. However, current monotherapy is unable to simultaneously reduce uric acid and suppress inflammation. We identified through bioinformatics and clinical sample analysis that oxidative stress‐related indicators were significantly elevated in patients with gouty arthritis. In light of this clinical finding, we developed a polydopamine‐based nanozyme with high superoxide dismutase and catalase activities via bimetallic ion coordination, which was subsequently loaded with uricase, rapamycin, and hyaluronic acid. In the gouty arthritis model, hyaluronic acid could target the CD44 receptor on the surface of macrophages, enhancing nanoprobe accumulation at the joint. The nanoprobe exhibited excellent biocompatibility and eliminated significantly monosodium urate crystals through multienzyme cascade reactions, while simultaneously addressing the accumulation of byproducts such as hydrogen peroxide, thereby markedly alleviating joint swelling and pain. In addition, the levels of Interleukin‐1 beta and Interleukin‐6 were significantly reduced, and the NF‐κB signaling pathway was effectively suppressed. The phenotypic of macrophages was transformed from pro‐inflammatory M1 to anti‐inflammatory M2 phenotype. Meanwhile, rapamycin effectively suppressed the immunogenicity of uricase and enhanced its therapeutic efficacy in vivo.
- 7 January 2026
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98 (2) , 1774-1782
Fouling-Proof Nanopore for Detecting Caspase-3 in Complex Biological Fluids
Caspase-3 plays a critical role in apoptosis and has been regarded as a key marker in apoptosis-related disease diagnosis and therapy. However, the Caspase-3 detection in complex biological environments remains challenging due to the existence of various interferences. To solve this challenge, an antifouling nanopore biosensor is constructed by integrating distearoylphosphatidyl ethanolamine-poly(ethylene glycol) (DSPE-PEG) and a Caspase-3-targeted peptide in a single glass nanopore, and it has been successfully used for the detection and analysis of Caspase-3 protease in complex biological environments. Contact angle, electrochemical, and confocal imaging characterizations confirm the good antifouling ability of the biosensor. The sensing performance of the biosensor was characterized by the change in the nanopore's rectified ionic current. The results indicated that the antifouling biosensor has a good detection performance for Caspase-3, with a detection limit of 0.46 ng/mL, and excellent selectivity against interfering proteins.
- 7 January 2026
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98 (2) , 1774-1782
Fouling-Proof Nanopore for Detecting Caspase-3 in Complex Biological Fluids
Caspase-3 plays a critical role in apoptosis and has been regarded as a key marker in apoptosis-related disease diagnosis and therapy. However, the Caspase-3 detection in complex biological environments remains challenging due to the existence of various interferences. To solve this challenge, an antifouling nanopore biosensor is constructed by integrating distearoylphosphatidyl ethanolamine-poly(ethylene glycol) (DSPE-PEG) and a Caspase-3-targeted peptide in a single glass nanopore, and it has been successfully used for the detection and analysis of Caspase-3 protease in complex biological environments. Contact angle, electrochemical, and confocal imaging characterizations confirm the good antifouling ability of the biosensor. The sensing performance of the biosensor was characterized by the change in the nanopore's rectified ionic current. The results indicated that the antifouling biosensor has a good detection performance for Caspase-3, with a detection limit of 0.46 ng/mL, and excellent selectivity against interfering proteins.
- Open Access
- 3 January 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Peptide-functionalized membrane camouflage for endogenous H2S-induced photothermal immunotherapy of orthotopic colorectal cancer
The significant challenges pose by the high recurrence and metastasis rates of colorectal cancer (CRC) persist in its diagnosis and treatment. Activating innate immunity in CRC treatment has the potential to reduce drug resistance and side effects. Here, we develop a biomimetic platform by utilizing antimicrobial peptide-functionalized CRC cell membranes to encapsulate a cobalt-based metal-organic framework (C), hereby called peptide-functionalized camouflage C (PfCC). When injected into tumour-bearing mice, PfCC will degrade under the acidic condition of the tumour microenvironment and release cobalt ions, which react with endogenous H 2 S to generate black stellate precipitates with good photothermal properties, recruiting NK cells and mitigates the immunosuppressive tumour-microenvironment. Simultaneously, the degradation of PfCC will release structure-protected antimicrobial peptides, inhibiting harmful bacteria, such as Desulfovibrio , and reducing H 2 S production. The abovementioned synergistic top-down regulation of H 2 S promote the polarization of macrophages and further activates the innate immune response. Moreover, experiments including the convex hull algorithm from AI deep learning of the segment anything model indicate that PfCC exhibites the most effective therapeutic effect compared with the single H 2 S-regulated therapeutic modality. Taken together, PfCC represents a potential anti-cancer therapy for CRC with the combined effect of immune-regulation and the regulation of the gut flora.
- 3 January 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessPeptide-functionalized membrane camouflage for endogenous H2S-induced photothermal immunotherapy of orthotopic colorectal cancer
The significant challenges pose by the high recurrence and metastasis rates of colorectal cancer (CRC) persist in its diagnosis and treatment. Activating innate immunity in CRC treatment has the potential to reduce drug resistance and side effects. Here, we develop a biomimetic platform by utilizing antimicrobial peptide-functionalized CRC cell membranes to encapsulate a cobalt-based metal-organic framework (C), hereby called peptide-functionalized camouflage C (PfCC). When injected into tumour-bearing mice, PfCC will degrade under the acidic condition of the tumour microenvironment and release cobalt ions, which react with endogenous H 2 S to generate black stellate precipitates with good photothermal properties, recruiting NK cells and mitigates the immunosuppressive tumour-microenvironment. Simultaneously, the degradation of PfCC will release structure-protected antimicrobial peptides, inhibiting harmful bacteria, such as Desulfovibrio , and reducing H 2 S production. The abovementioned synergistic top-down regulation of H 2 S promote the polarization of macrophages and further activates the innate immune response. Moreover, experiments including the convex hull algorithm from AI deep learning of the segment anything model indicate that PfCC exhibites the most effective therapeutic effect compared with the single H 2 S-regulated therapeutic modality. Taken together, PfCC represents a potential anti-cancer therapy for CRC with the combined effect of immune-regulation and the regulation of the gut flora.
- 22 December 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98 (6) , 4538-4547
A Laser-Engraved Wearable Patch Aptasensor Based on Tetrahedral DNA Nanostructures for In Situ Detection of Cortisol in Sweat
Psychological stress is a common complex emotional state in humans, and if it accumulates over a long period of time, it can lead to serious psychological problems. The accurate detection of cortisol, an important indicator of the body's response to stress, is crucial for health assessment, psychological state analysis, and the diagnosis of stress-related diseases. To this end, this study prepared a wearable electrochemical aptasensor based on tetrahedral DNA nanostructures and gold nanoparticle-modified laser-engraved graphene (LEG), achieving simple, efficient, and noninvasive cortisol detection. Among them, LEG obtained by direct laser irradiation of polyimide is considered an ideal electrode due to its excellent conductivity. Using methylene blue (MB) as the signal molecule, the conformational change induced by the aptamer-cortisol binding alters the distance between MB and the electrode surface, thereby generating a detectable signal change. In addition, microfluidic devices can quickly collect sweat, effectively avoiding evaporation and contamination issues. By integrating laser-engraved electrodes with microfluidic devices, we have achieved in situ monitoring of cortisol in sweat. The sensor exhibits high sensitivity and excellent specificity, with a linear range of 1 pg/mL-1 μg/mL in artificial sweat and a detection limit as low as 1.06 × 10-2 pg/mL. Furthermore, this method has been successfully applied to the in situ detection of cortisol in sweat, demonstrating the broad application prospects of wearable sensors for detecting sweat biomarkers.
- 22 December 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98 (6) , 4538-4547
A Laser-Engraved Wearable Patch Aptasensor Based on Tetrahedral DNA Nanostructures for In Situ Detection of Cortisol in Sweat
Psychological stress is a common complex emotional state in humans, and if it accumulates over a long period of time, it can lead to serious psychological problems. The accurate detection of cortisol, an important indicator of the body's response to stress, is crucial for health assessment, psychological state analysis, and the diagnosis of stress-related diseases. To this end, this study prepared a wearable electrochemical aptasensor based on tetrahedral DNA nanostructures and gold nanoparticle-modified laser-engraved graphene (LEG), achieving simple, efficient, and noninvasive cortisol detection. Among them, LEG obtained by direct laser irradiation of polyimide is considered an ideal electrode due to its excellent conductivity. Using methylene blue (MB) as the signal molecule, the conformational change induced by the aptamer-cortisol binding alters the distance between MB and the electrode surface, thereby generating a detectable signal change. In addition, microfluidic devices can quickly collect sweat, effectively avoiding evaporation and contamination issues. By integrating laser-engraved electrodes with microfluidic devices, we have achieved in situ monitoring of cortisol in sweat. The sensor exhibits high sensitivity and excellent specificity, with a linear range of 1 pg/mL-1 μg/mL in artificial sweat and a detection limit as low as 1.06 × 10-2 pg/mL. Furthermore, this method has been successfully applied to the in situ detection of cortisol in sweat, demonstrating the broad application prospects of wearable sensors for detecting sweat biomarkers.
- Open Access
- 8 December 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 43325
Dracorhodin perchlorate alleviates sciatic nerve pain in CCI rats by modulating inflammation and promoting nerve repair
This study analyzed protein sequencing from rat samples, categorized into a control group (Chronic Constriction Injury, CCI) and test (treated with dracorhodin perchlorate, DP), The purpose of this study was to identify key target proteins of DP in the treatment of sciatica and elucidate its underlying mechanisms. By comparing the differentially expressed proteins (DEPs) of the two groups at 1, 3, and 7 days post - treatment, it was revealed that DP consistently and significantly downregulated the expression of the Interleukin-6 (IL-6) and the cytokine-Induced neutrophil chemoattractant-3 (CINC-3), while significantly upregulating the expression of the neurotrophic factor ciliary neurotrophic factor (CNTF). Functional enrichment analysis indicated that these DEPs are primarily involved in inflammatory signaling pathways, nerve repair, and the chemotaxis of neutrophils. Validation via Western blot and ELISA demonstrated that the expression levels of IL-6 and CINC-3 were significantly reduced in the DP group, whereas the expression level of CNTF was significantly elevated, thereby confirming the significant therapeutic effect of DP on sciatica. Furthermore, experiments using a zebrafish inflammation model further confirmed that DP could significantly inhibit the recruitment and migration of neutrophils. In summary, this study not only uncovered potential target proteins for DP in the treatment of sciatica but also provided crucial evidence for its mechanism of action, suggesting that DP may effectively alleviate sciatica by downregulating IL-6 and CINC-3, inhibiting neutrophil migration, and upregulating CNTF to promote neurotrophic effects.
- 8 December 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 43325
Open AccessDracorhodin perchlorate alleviates sciatic nerve pain in CCI rats by modulating inflammation and promoting nerve repair
This study analyzed protein sequencing from rat samples, categorized into a control group (Chronic Constriction Injury, CCI) and test (treated with dracorhodin perchlorate, DP), The purpose of this study was to identify key target proteins of DP in the treatment of sciatica and elucidate its underlying mechanisms. By comparing the differentially expressed proteins (DEPs) of the two groups at 1, 3, and 7 days post - treatment, it was revealed that DP consistently and significantly downregulated the expression of the Interleukin-6 (IL-6) and the cytokine-Induced neutrophil chemoattractant-3 (CINC-3), while significantly upregulating the expression of the neurotrophic factor ciliary neurotrophic factor (CNTF). Functional enrichment analysis indicated that these DEPs are primarily involved in inflammatory signaling pathways, nerve repair, and the chemotaxis of neutrophils. Validation via Western blot and ELISA demonstrated that the expression levels of IL-6 and CINC-3 were significantly reduced in the DP group, whereas the expression level of CNTF was significantly elevated, thereby confirming the significant therapeutic effect of DP on sciatica. Furthermore, experiments using a zebrafish inflammation model further confirmed that DP could significantly inhibit the recruitment and migration of neutrophils. In summary, this study not only uncovered potential target proteins for DP in the treatment of sciatica but also provided crucial evidence for its mechanism of action, suggesting that DP may effectively alleviate sciatica by downregulating IL-6 and CINC-3, inhibiting neutrophil migration, and upregulating CNTF to promote neurotrophic effects.
- Open Access
- 5 December 2025
- Published by Frontiers Media SA in Frontiers in Molecular Neuroscience
- Vol. 18, 1674151
Unraveling proteomic signatures and neuroinflammatory networks in a CCI rat model of early sciatica: insights for neuropathic pain mechanisms
Introduction: Sciatica is a prevalent and highly debilitating condition that is clinically characterized by pain radiating along the distribution of the sciatic nerve. Despite its common occurrence, the progression of early sciatica remains not yet fully elucidated. The aim of this study is to explore the potential molecular mechanism underlying early-stage sciatica progression. Methods: A total of 20 rats were collected, with 9 in the control group and 11 rats in the chronic constriction injury (CCI) model group. The sciatic nerve tissues of rats were collected at three time points 1, 3, and 7 days post surgery. Protein microarray was used to detect the expression levels of 27 cytokines in sciatic nerve tissues at different times. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) were used for functional and pathway analysis of the differentially expressed proteins (DEPs). ELISA was used to detect the levels of chemokine CINC-2 and neurotrophic growth factors (CNTF). Results: A total of 11 proteins showed significant differential expression between the CCI and control groups at all three time points (days 1, 3, and 7) after sciatic nerve injury. Specifically, Cytokine-Induced Neutrophil Chemoattractant-2 (CINC-2), Cytokine-Induced Neutrophil Chemoattractant-3 (CINC-3), Lipopolysaccharide-Induced CXC chemokine (LIX), Lymphocyte-Selectin (L-Selectin), Platelet-Derived Growth Factor-AA (PDGF-AA), Interleukin-1 alpha (IL-1α), Interleukin-6 (IL-6), Tissue Inhibitor of Metalloproteinase-1 (TIMP-1), and beta-Nerve Growth Factor ( β -NGF) were significantly upregulated ( p < 0.05), whereas the neurotrophic-related protein CNTF was significantly downregulated ( p < 0.05). KEGG pathway analysis revealed that these DEPs were primarily enriched in key inflammatory signaling pathways, including the JAK–STAT, Cytokine-cytokine receptor interaction, Chemokine, Tumor Necrosis Factor (TNF), NOD-like receptor, and NF-kappa B signaling pathways. GO analysis indicated their involvement in biological processes such as immune response and cellular chemotaxis. Protein function analysis further confirmed the close correlation of these DEPs with cellular recognition and neuroinflammation. Additionally, ELISA validation showed that the key protein CINC-2 was upregulated and CNTF was significantly downregulated in the early CCI group. Discussion: The progression of early sciatic is closely associated with neuroinflammation triggered by the overexpression of inflammatory factors and nerve dysfunction mediated by neurotrophic-related proteins.
- 5 December 2025
- Published by Frontiers Media SA in Frontiers in Molecular Neuroscience
- Vol. 18, 1674151
Open AccessUnraveling proteomic signatures and neuroinflammatory networks in a CCI rat model of early sciatica: insights for neuropathic pain mechanisms
Introduction: Sciatica is a prevalent and highly debilitating condition that is clinically characterized by pain radiating along the distribution of the sciatic nerve. Despite its common occurrence, the progression of early sciatica remains not yet fully elucidated. The aim of this study is to explore the potential molecular mechanism underlying early-stage sciatica progression. Methods: A total of 20 rats were collected, with 9 in the control group and 11 rats in the chronic constriction injury (CCI) model group. The sciatic nerve tissues of rats were collected at three time points 1, 3, and 7 days post surgery. Protein microarray was used to detect the expression levels of 27 cytokines in sciatic nerve tissues at different times. Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) were used for functional and pathway analysis of the differentially expressed proteins (DEPs). ELISA was used to detect the levels of chemokine CINC-2 and neurotrophic growth factors (CNTF). Results: A total of 11 proteins showed significant differential expression between the CCI and control groups at all three time points (days 1, 3, and 7) after sciatic nerve injury. Specifically, Cytokine-Induced Neutrophil Chemoattractant-2 (CINC-2), Cytokine-Induced Neutrophil Chemoattractant-3 (CINC-3), Lipopolysaccharide-Induced CXC chemokine (LIX), Lymphocyte-Selectin (L-Selectin), Platelet-Derived Growth Factor-AA (PDGF-AA), Interleukin-1 alpha (IL-1α), Interleukin-6 (IL-6), Tissue Inhibitor of Metalloproteinase-1 (TIMP-1), and beta-Nerve Growth Factor ( β -NGF) were significantly upregulated ( p < 0.05), whereas the neurotrophic-related protein CNTF was significantly downregulated ( p < 0.05). KEGG pathway analysis revealed that these DEPs were primarily enriched in key inflammatory signaling pathways, including the JAK–STAT, Cytokine-cytokine receptor interaction, Chemokine, Tumor Necrosis Factor (TNF), NOD-like receptor, and NF-kappa B signaling pathways. GO analysis indicated their involvement in biological processes such as immune response and cellular chemotaxis. Protein function analysis further confirmed the close correlation of these DEPs with cellular recognition and neuroinflammation. Additionally, ELISA validation showed that the key protein CINC-2 was upregulated and CNTF was significantly downregulated in the early CCI group. Discussion: The progression of early sciatic is closely associated with neuroinflammation triggered by the overexpression of inflammatory factors and nerve dysfunction mediated by neurotrophic-related proteins.
- Open Access
- 27 April 2025
- Published by Wiley in Advanced Science
- Vol. 12 (27) , e2505000
Engineered Bacterial Outer Membrane Vesicles Hitchhiking on Neutrophils for Antibody Drug Delivery to Enhance Postoperative Immune Checkpoint Therapy
In clinical practice, surgical removal of tumors often leaves behind small tumors and circulating tumor cells, increasing the risk of metastasis and recurrence, which seriously affects treatment outcomes. Immunotherapy activates the immune system to monitor and inhibit tumor metastasis and recurrence long‐term. However, inflammatory microenvironments at surgical sites lead to immunosuppressive tumor‐associated macrophages (TAMs), causing immune evasion. Additionally, tumor cells overexpress the immune checkpoint CD47, further weakening the phagocytic and cytotoxic functions of macrophages. Here, the bacterial outer membrane vesicles (OMV) hitchhiking on neutrophils are utilized to precisely deliver immune checkpoint blockade antibodies to the tumor resection site. Escherichia coli is reprogrammed to express CD47 antibody and used to extract CD47 antibody‐containing OMV, followed by insertion of Ce6 photosensitizer into the membrane (OC47‐Ce6). Purified autologous neutrophils phagocytose and carry OC47‐Ce6 for precise targeting to the postoperative tumor resection site, mediating tumor cell killing, aCD47 release, and tumor‐associated antigen presentation by light. In vitro and in vivo experiments demonstrate that OC47‐Ce6 enhances TAM phagocytic function through TAM polarization and CD47 blockade. This approach effectively activates T‐cell anti‐tumor immune responses and significantly reduces the risk of postoperative tumor recurrence and metastasis.
- 27 April 2025
- Published by Wiley in Advanced Science
- Vol. 12 (27) , e2505000
Open AccessEngineered Bacterial Outer Membrane Vesicles Hitchhiking on Neutrophils for Antibody Drug Delivery to Enhance Postoperative Immune Checkpoint Therapy
In clinical practice, surgical removal of tumors often leaves behind small tumors and circulating tumor cells, increasing the risk of metastasis and recurrence, which seriously affects treatment outcomes. Immunotherapy activates the immune system to monitor and inhibit tumor metastasis and recurrence long‐term. However, inflammatory microenvironments at surgical sites lead to immunosuppressive tumor‐associated macrophages (TAMs), causing immune evasion. Additionally, tumor cells overexpress the immune checkpoint CD47, further weakening the phagocytic and cytotoxic functions of macrophages. Here, the bacterial outer membrane vesicles (OMV) hitchhiking on neutrophils are utilized to precisely deliver immune checkpoint blockade antibodies to the tumor resection site. Escherichia coli is reprogrammed to express CD47 antibody and used to extract CD47 antibody‐containing OMV, followed by insertion of Ce6 photosensitizer into the membrane (OC47‐Ce6). Purified autologous neutrophils phagocytose and carry OC47‐Ce6 for precise targeting to the postoperative tumor resection site, mediating tumor cell killing, aCD47 release, and tumor‐associated antigen presentation by light. In vitro and in vivo experiments demonstrate that OC47‐Ce6 enhances TAM phagocytic function through TAM polarization and CD47 blockade. This approach effectively activates T‐cell anti‐tumor immune responses and significantly reduces the risk of postoperative tumor recurrence and metastasis.
- Open Access
- 28 March 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (13) , eadt7298
Programmable engineered bacteria as sustained-releasing antibody factory in situ for enhancing tumor immune checkpoint therapy
Tumor immune checkpoint therapy (ICT) aims to block immune escape signals between tumor and immune cells. However, low delivery efficiency of immune checkpoint inhibitors (ICIs), narrow single-target approach, and reduced responsiveness notably hinder clinical development of ICT. Here, we developed a nanoliposome-bacteria hybrid system that acts as an antibody (Ab) factory, enabling precise tumor targeting and macrophage activation in hypoxic environments. We reprogrammed attenuated Escherichia coli MG1655 to synthesize CD47 antibodies (aCD47) in response to hypoxic tumor microenvironments while surface conjugating with redox-responsive macrophage colony-stimulating factor-loaded liposomes. This system leverages bacterial tropism to enhance macrophage infiltration and polarization. The low oxygen levels trigger in situ aCD47 expression, blocking the “do not eat me” signal and boosting macrophage antitumor activity. In addition, macrophage antigen presentation activates CD8+CD3+ T cells, amplifying systemic antitumor immunity. Analysis of the gut microbiome shows reduced pathogenicity and improved intestinal tolerance with increased probiotics.
- 28 March 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (13) , eadt7298
Open AccessProgrammable engineered bacteria as sustained-releasing antibody factory in situ for enhancing tumor immune checkpoint therapy
Tumor immune checkpoint therapy (ICT) aims to block immune escape signals between tumor and immune cells. However, low delivery efficiency of immune checkpoint inhibitors (ICIs), narrow single-target approach, and reduced responsiveness notably hinder clinical development of ICT. Here, we developed a nanoliposome-bacteria hybrid system that acts as an antibody (Ab) factory, enabling precise tumor targeting and macrophage activation in hypoxic environments. We reprogrammed attenuated Escherichia coli MG1655 to synthesize CD47 antibodies (aCD47) in response to hypoxic tumor microenvironments while surface conjugating with redox-responsive macrophage colony-stimulating factor-loaded liposomes. This system leverages bacterial tropism to enhance macrophage infiltration and polarization. The low oxygen levels trigger in situ aCD47 expression, blocking the “do not eat me” signal and boosting macrophage antitumor activity. In addition, macrophage antigen presentation activates CD8+CD3+ T cells, amplifying systemic antitumor immunity. Analysis of the gut microbiome shows reduced pathogenicity and improved intestinal tolerance with increased probiotics.
- 26 March 2025
- Published by American Chemical Society (ACS) in ACS Materials Letters
- Vol. 7 (4) , 1593-1602
Camouflaging Attenuated Salmonella by Detachable Metal Polyphenol Nanoshells for Enhanced Bacteria-Based Cancer Immunotherapy
- 26 March 2025
- Published by American Chemical Society (ACS) in ACS Materials Letters
- Vol. 7 (4) , 1593-1602
Camouflaging Attenuated Salmonella by Detachable Metal Polyphenol Nanoshells for Enhanced Bacteria-Based Cancer Immunotherapy